A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients

Clinical trial NCT03035032 · COMPLETED

Trial details

NCT number: NCT03035032
Sponsor: Astellas Pharma Singapore Pte. Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2017-06-23
Primary completion: 2019-11-19
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.